Detalhe da pesquisa
1.
Distinct roles of IL-18 and IL-1ß in murine model of macrophage activation syndrome.
J Allergy Clin Immunol
; 152(4): 940-948.e6, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352976
2.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Br J Cancer
; 128(10): 1897-1905, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871043
3.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
N Engl J Med
; 382(25): 2419-2430, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469182
4.
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Gastric Cancer
; 26(1): 132-144, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316527
5.
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer.
Cancer Sci
; 113(8): 2814-2827, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701865
6.
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case report.
Invest New Drugs
; 40(5): 1137-1140, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657573
7.
Effects of long-term treatment with dietary theobromine on rat skeletal muscles.
Mol Biol Rep
; 49(5): 3965-3973, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226259
8.
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Int J Clin Oncol
; 27(9): 1450-1458, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861943
9.
Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701.
Int J Clin Oncol
; 26(10): 1871-1880, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453640
10.
Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic Escherichia coli induced hemolytic uremic syndrome.
Ren Fail
; 43(1): 382-387, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641616
11.
Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials.
Int J Clin Oncol
; 25(9): 1635-1643, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32494981
12.
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).
Int J Clin Oncol
; 25(8): 1515-1522, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409917
13.
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).
Int J Clin Oncol
; 25(7): 1291-1298, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219630
14.
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
Int J Clin Oncol
; 25(4): 614-621, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838590
15.
Salivary Immunoglobulin A Secretion and Polymeric Ig Receptor Expression in the Submandibular Glands Are Enhanced in Heat-Acclimated Rats.
Int J Mol Sci
; 21(3)2020 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32012687
16.
[A Phase â ¡ Study of Systemic Chemotherapy with Capecitabine and Cisplatin Followed by Surgery for Advanced Gastric Cancer with Extensive Lymph Node Metastasis(OGSG1401)].
Gan To Kagaku Ryoho
; 47(3): 481-483, 2020 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-32381922
17.
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
Cancer Sci
; 110(11): 3565-3572, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31520559
18.
Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.
Cancer Sci
; 110(9): 2875-2883, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31254422
19.
Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.
Cancer Sci
; 110(3): 1032-1043, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657223
20.
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
Oncologist
; 24(3): 327-337, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425180